Medical Cannabis Evidence-Based Care: CBD for Fibromyalgia
This article reviews cannabinoid clinical trials CBD for fibromyalgia evidence. Current research shows CBD did not outperform placebo in reducing fibromyalgia pain. Clinicians should set realistic expectations for patients considering CBD treatment.
Endocannabinoid System & Adolescent Health: 15-Year REAL 2.0
This 15-year adolescent health research examines how early body image concerns and disordered eating impact later mental health and substance use. The endocannabinoid system plays a role in these developmental trajectories. Understanding these links aids…
Challenges in Mental Health of Retired Professional Athletes
Mental health retired professional athletes challenges include elevated depression, anxiety, and cognitive concerns compared to the general population. Key factors influencing these outcomes are concussion history, social identity loss, and physical…
Cannabinoids in Pediatric Medicine: Research and Clinical Insights
Cannabinoids for pediatric medicine have been studied in various medical conditions, with strongest evidence for refractory epilepsy. Current research highlights safety and efficacy concerns in pediatric care. Clinicians should use updated evidence to…
Cannabinoid Clinical Trials: CBD for Fibromyalgia Pain
This randomized, double-blind, placebo-controlled trial evaluated CBD for fibromyalgia pain. Results showed CBD did not outperform placebo in reducing pain intensity. These findings highlight the need for cautious interpretation of CBD for fibromyalgia…
Endocannabinoid System Clinical Research: Eating Disorders
This article covers endocannabinoid system adolescent eating disorder research focusing on how adolescent risk factors contribute to eating disorders. The study highlights the importance of early screening for disordered eating and body image concerns.…
Clinical Research on Endocannabinoid System in Mental Health RCTs
This study examines endocannabinoid system clinical research mental health RCTs evaluating the Minder mobile app for university students. The trial tests digital tools addressing mental health and substance use challenges. Results provide clinical…
Endocannabinoid System Research: Cannabinoids for Children
Cannabinoids for pediatric care have been studied in various medical conditions with evolving evidence. The strongest data supports use in specific epilepsy syndromes. Safety and efficacy findings in other pediatric conditions remain limited and variable.
AM Policy Update: March 11, 2026 – DEA Rescheduling Marijuana
The DEA rescheduling marijuana update on March 11, 2026, marks a significant federal regulatory change. This update affects cannabis medicine by recognizing its medical potential. It highlights the evolving landscape of controlled substances and federal…
AM Study Update: March 11, 2026
This AM Study Update highlights cannabis clinical research 2026 with 20 prioritized studies from PubMed. The update covers clinical trials and systematic reviews relevant to cannabis medicine. Clinicians will find evidence-based insights for March 11,…